Page last updated: 2024-10-29

ifosfamide and Actinomycetoma

ifosfamide has been researched along with Actinomycetoma in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We developed an in vitro susceptibility assay for Actinomadura madurae, one of the common causative agents of actinomycetoma, employing resazurin for endpoint reading."8.12Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma. ( Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A, 2022)
"We developed an in vitro susceptibility assay for Actinomadura madurae, one of the common causative agents of actinomycetoma, employing resazurin for endpoint reading."4.12Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma. ( Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abd Algaffar, SO1
Verbon, A1
Khalid, SA1
van de Sande, WWJ1

Other Studies

1 other study available for ifosfamide and Actinomycetoma

ArticleYear
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
    The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosf

2022